Citations

Clear

6 citation(s) found for "Livingston, David".

Sequential Protocol Biopsies Post–Liver Transplant From Donors With Moderate Macrosteatosis: What Happens to the Fat?
Croome, Kristopher P. , Livingston, David H. , Croome, Sarah, Nakhleh, Raouf E. , Croome, Kris P , Livingston, David, Keaveny, Andrew P. , Taner, C. Burcin

Mayo Clinic

Liver Transplantation | August 11, 2020 | Volume: 27 | Issue: 2 | Pages: 248-256

10.1002/lt.25867 | PMID 32779325 Get It

The number of steatotic deceased donor livers encountered has continued to rise as a result of the obesity epidemic. Little is known about the histological characteristics of moderately macrosteatotic livers over time in the recipient following liver transplantation (LT). All recipients undergoing LT at Mayo Clinic Florida with donor livers with moderate macrosteatosis (30%‐60%) from 2000‐2017 were identified (n = 96). Routine protocol liver biopsies were performed 1‐week and 6‐months following LT. All liver donor and protocol biopsies were read by an experienced liver pathologist. Of the 96 moderate macrosteatosis LTs, 70 recipients had post‐LT protocol liver biopsies available and comprised the study cohort. Median donor allograft macrosteatosis at the time of transplant was 33% (IQR, 30%‐40%) compared with 0% (IQR, 0%‐2%) at 1‐week (P < 0.001) and 0% (IQR, 0%‐0%) at 6‐months (P < 0.001) following LT. Biopsies at 1‐week post‐LT displayed pericentral necrosis in 57.1% of recipients and lipopeliosis in 34.3% of recipients. In the 6‐month post‐LT biopsies, cholestasis was seen in 3 (4.3%) of the recipients, whereas grade 2 fibrosis was seen in 6 recipients (8.6%). Graft survival at 5 years in the present cohort was 74.0%. Moderate macrosteatosis (30%‐60%) in the donor allograft demonstrates complete reversal on liver biopsies performed as early as 7 days following LT and remains absent at 6‐months following LT. Both pericentral necrosis and lipopeliosis are common features on day 7 biopsies. Despite these encouraging findings, the perioperative risks of using these livers (postreperfusion cardiac arrest and primary nonfunction) should not be understated. Long‐term graft survival is acceptable in patients who are able to overcome the immediate perioperative risk of using moderately steatotic donor livers.
Absent, Abnormal, or Reduced Flow in the Testis: Thinking Beyond Torsion
Alexander, Lauren F. , Caserta, Melanie P. , Baden, Kerri , Livingston, David H. , Cernigliaro, Joseph G. , Bhatt, Shweta , Livingston, David , Alexander, Lauren F , Bhatt, Shweta

Mayo Clinic

RadioGraphics | March 3, 2020 | Volume: 40 | Issue: 2 | Pages: 529-530

10.1148/rg.2020190111 | PMID 32125958 Get It

Signs of Increased Intrapericardial Pressure on Chest Computed Tomography
Rojas, Carlos, Padilla, Gary, Feldhaus, Jacob M., Rajan, Celin, Shapiro, Brian P. , Mergo, Patricia J. , Livingston, David H. , Bowman, Andrew W.

Mayo Clinic

Journal of Thoracic Imaging | February 7, 2020 | Volume: 35 | Issue: 3 | Pages: 143-152

10.1097/rti.0000000000000475 | PMID 32073542 Get It

We sought to describe incidental imaging features of increased intrapericardial pressure due to pericardial effusion on chest computed tomography (CT) and correlate them with cardiac CT, cardiac magnetic resonance imaging, and echocardiography. It is important for the radiologist to become familiar with imaging findings of increased intrapericardial pressure in the setting of pericardial effusion when identified on chest CT. Recognizing the imaging findings of increased intrapericardial pressure can better guide the care of these patients.
Comparison of Supraceliac and Infrarenal Aortic Conduits in Liver Transplantation: Is There a Difference in Patency and Postoperative Renal Dysfunction?
Livingston, David H. , Lee, David D. , Croome, Sarah, Croome, Kristopher P. , Livingston, David, Croome, Kris P , Lee, David D , Livingston, David, Taner, C. Burcin

Mayo Clinic

Transplantation Direct | October 10, 2019 | Volume: 5 | Issue: 11 | Pages: e499

10.1097/txd.0000000000000949 | PMID 31773052 Get It

Background. Aorto-hepatic conduits can provide arterial inflow for liver transplants in cases where the native hepatic artery is unsuitable for use. Methods. Clinical outcomes of all patients undergoing liver transplantation (LT) with an aorto-hepatic conduit between 2000 and 2016 were included. Recipients were divided into 2 groups: those with a supraceliac (SC) aortic conduit (N = 22) and those with an infrarenal (IR) aortic conduit (N = 82). Results. There was no difference in calculated model for end-stage liver disease score between the 2 groups. The SC group received grafts with a higher mean donor risk index (1.69 versus 1.48; P = 0.02). Early allograft dysfunction was 18.2% in the SC group and 29.3% in the IR group (P = 0.30). In the SC group, 10.5% of patients required initiation of postoperative continuous renal replacement therapy compared to 12.1% of patients in the IR group (P = 0.69). No difference in the rate of postoperative acute kidney injury was seen between the 2 groups (P = 0.54). No significant difference in median creatinine at 1 year was seen between the SC (1.2 mg/dL; IQR 1–1.3) and IR (1.2 mg/dL; IQR 0.9–1.5) groups (P = 0.85). At a median follow-up of 5.3 years, thrombosis of the aortic conduit occurred in 0% of patients in the SC group and 6.1% of patients in the IR group (P = 0.24). Graft survival was not significantly different between the 2 groups (P = 0.47). Conclusions. No difference in renal dysfunction as demonstrated by need for post-LT continuous renal replacement therapy, acute kidney injury, or creatinine at 1 year post-LT was seen between SC and IR aortic conduits. A slight trend of higher conduit thrombosis rate was seen with IR compared to SC aortic conduits; however, this did not reach statistical significance. Both SC and IR aortic conduits represent reasonable options when the native hepatic artery is unsuitable for use.
Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity‐Matched Cohort
Croome, Kristopher P. , Lee, David D. , Croome, Sarah, Nakhleh, Raouf E. , Senada, Peter A., Yataco, Maria, Abader Sedki Senada, Peter, Livingston, David, Taner, C. Burcin , Croome, Kris P , Lee, David D , Livingston, David H.

Mayo Clinic

Liver Transplantation | June 12, 2019 | Volume: 25 | Issue: 10 | Pages: 1533-1540

10.1002/lt.25583 | PMID 31187923 Get It

It has been suggested that microsteatosis does not negatively impact graft survival following liver transplantation (LT). The present study represents the largest series on donor livers with significant microsteatosis and investigates the impact of microsteatosis on perioperative factors such as postreperfusion syndrome (PRS), early allograft dysfunction (EAD), and postoperative renal dysfunction. Clinical outcomes of all patients undergoing LT with donor livers with isolated microsteatosis (≥30%; n = 239) between 2000 and 2017 were compared with a propensity score–matched cohort of patients undergoing LT with donor livers with no steatosis (n = 239). Patients in the microsteatosis group had a higher rate of PRS (33.1% versus 24.2%; P = 0.03), EAD (38.2% versus 23.0%; P < 0.001), and continuous renal replacement therapy (CRRT) requirement following LT (10.9% versus 3.6%; P = 0.002) than the no steatosis group. No difference in patient (P = 0.33) or graft survival (P = 0.18) was observed between the 2 groups. On multivariate regression, livers with microsteatosis had an increased risk of graft loss with retransplant recipients (hazard ratio [HR], 1.59; P < 0.001), increasing Model for End‐Stage Liver Disease (MELD) score (HR, 1.13; P = 0.01), and organs from donation after circulatory death donors (HR, 1.46; P = 0.003). In conclusion, recipients of donor livers with significant microsteatosis are at an increased risk of PRS, EAD, and postoperative renal dysfunction requiring CRRT. Livers with significant microsteatosis should be avoided in retransplant recipients and in recipients with high biological MELD scores. Once appropriately selected recipients of these livers are able to overcome the initial perioperative implications of using these donor livers, longterm patient and graft survival is similar to recipients receiving grafts with no steatosis.
“Tram-line” Calcifications in Granulomatosis with Polyangiitis
Livingston, David H. , Rajan, Celin, McKinney, J. Mark , Livingston, David, Bhatt, Shweta , Livingston, David

Mayo Clinic

Journal of Clinical Imaging Science | May 14, 2019 | Volume: 9 | Issue: No issue available | Pages: 13

10.25259/jcis-5-2019 | PMID 31448164 Get It

Nephrocalcinosis consists of deposition of calcium in the renal parenchyma. Renal cortical calcification is a rare entity in comparison to calcium deposits in the medulla and is seen only in a handful of pathologies with corresponding characteristic patterns on imaging. Thin linear calcifications may get deposited in the peripheral renal cortex suggestive of cortical necrosis due to a vascular insult (vasculitis), and rarely due to glomerulonephritis. This pattern of calcification has also been referred to as the “tramline” or “railroad track” sign.